Details of the Drug

General Information of Drug (ID: DMSE8XX)

Drug Name
SAR256212
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 2 [1]
Cross-matching ID
TTD ID
D05YLN

References

1 Clinical pipeline report, company report or official report of Merrimack Pharmaceuticals.